1. Why not use data intensive science to build models of disease within a commons? Power of a Compute Space/Beyond Current Reward Structures Five Pilots- Missing Ingredients…
1. Arch2POCMA Drug Development Approachfrom Disease Targets to their Clinical Validation Stephen FriendSage Bionetworks (a non-profit foundation) IBC San FranciscoAug 3,…
1. it is more about how we do science than whatadvantages of an open innovation compute spacefor building better models of diseasebeyond siloed drug discovery- Arch2POCM…